Insider Selling: Synopsys (NASDAQ:SNPS) Insider Sells $10,335,421.04 in Stock

Synopsys, Inc. (NASDAQ:SNPS) insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the completion of the transaction, the insider owned 120,443 shares of the company’s stock, valued at approximately $50,518,611.92. This represents a 16.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Geus Aart De also recently made the following trade(s):

• On Monday, August 31st, Aart de Geus sold 25,000 shares of Synopsys stock. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00.
• On Friday, August 28th, Aart de Geus sold 25,000 shares of Synopsys stock. The shares were sold at an average price of $445.55, for a total transaction of $11,138,750.00.

Synopsys Trading Down 5.4%

NASDAQ SNPS opened at $393.84 on Friday. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The firm’s 50-day moving average is $412.27 and its two-hundred day moving average is $439.47. The stock has a market capitalization of $75.48 billion, a P/E ratio of 69.58, a PEG ratio of 2.28 and a beta of 1.23.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period last year, the firm earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.97 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Weiss Ratings raised shares of Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. UBS Group set a $570.00 price objective on Synopsys in a report on Thursday, August 27th. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a report on Wednesday, May 27th. Rosenblatt Securities reaffirmed a “buy” rating and set a $575.00 price objective on shares of Synopsys in a report on Tuesday, August 25th. Finally, BNP Paribas Exane increased their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Twelve investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $561.28.

Hedge Funds Weigh In On Synopsys

A number of institutional investors have recently added to or reduced their stakes in SNPS. Sankala Group LLC purchased a new stake in Synopsys during the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC raised its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after acquiring an additional 27 shares in the last quarter. Osbon Capital Management LLC acquired a new stake in Synopsys in the second quarter valued at $25,000. IMG Wealth Management Inc. acquired a new stake in Synopsys during the second quarter valued at approximately $28,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in Synopsys during the fourth quarter valued at $28,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys reported fiscal third-quarter revenue of approximately $2.48 billion and non-GAAP EPS of $3.91, exceeding analyst estimates of $2.44 billion and $3.67, respectively. Revenue grew 42.4% year over year, underscoring continued demand for electronic-design automation and semiconductor IP. Synopsys Results Analysis
• Positive Sentiment: Analysts continue to see significant long-term upside, with reported price targets generally ranging from $450 to $610 and a consensus “Moderate Buy” rating. The bullish case centers on Synopsys’ strategic importance to advanced chip and AI design. Synopsys Wall Street Price Targets
• Neutral Sentiment: Institutional positioning is mixed: 769 investors added SNPS shares in their latest reported quarter, while 764 reduced positions. This suggests continued interest but limited consensus among large investors. Synopsys Institutional Activity
• Negative Sentiment: The earnings beat did not translate into a sufficiently large outlook increase for a stock priced for stronger growth. Full-year guidance implies approximately $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint, prompting a potential “sell-the-news” reaction.
• Negative Sentiment: Investors remain concerned about execution and margin pressure from the Ansys integration. Synopsys reported roughly $236.3 million in restructuring charges during the first nine months of fiscal 2026, while acquired-intangible amortization and approximately $10 billion of debt add to acquisition-related financial risks. Synopsys Ansys Integration Analysis
• Negative Sentiment: Executive Chair Aart de Geus sold 49,641 shares for approximately $21.4 million across August 28, August 31 and September 1. The transactions were made under a pre-arranged Rule 10b5-1 plan, reducing their value as a discretionary bearish signal, but the selling may still weigh on sentiment. Synopsys Insider Selling
• Negative Sentiment: SNPS remains sensitive to higher interest rates and semiconductor-sector weakness. Its valuation remains demanding, with a reported P/E ratio above 69, while the stock is trading below its 200-day moving average. Is Synopsys Stock Underperforming the Nasdaq?

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.